4th NASH Roundtable Virtual Forum
November 18, 2021 at 11:30 AM PST / 2:30 PM EST.

Learn More »


Fact Sheet: NASH Roundtable, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »


September, 2021

Randomized clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. Read More »

September, 2021

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease. Read More »

September, 2021

A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Non-alcoholic Fatty Liver Disease. Read More »

September, 2021

Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. Read More »